Asthma in the UK: Why Trials Matter Now
Around 5.4 million people in the UK live with asthma, and roughly 200,000 of them have a severe form that does not respond well to standard inhalers. Lung disease is now the third most common cause of death in the country, costing the NHS more than £9 billion each year. These numbers are not abstract — they translate into missed school days, cancelled holidays, and nights spent in A&E waiting rooms.
What makes the UK an especially active hub for asthma clinical trials is the combination of a centralised health system and world-class research infrastructure. The National Institute for Health and Care Research (NIHR) coordinates studies across dozens of NHS trusts, meaning patients in cities like Manchester, Birmingham, Glasgow, and Cardiff can access trials without travelling to London. This geographic spread matters because asthma prevalence and triggers vary by region. In urban areas with higher pollution levels, researchers are particularly interested in how environmental factors interact with new biologic treatments.
The current wave of trials focuses on several fronts. Biologic therapies — injectable monoclonal antibodies such as tezepelumab and benralizumab — target specific inflammatory pathways rather than broadly suppressing the immune system the way oral steroids do. A separate line of research, led by the University of Southampton, is investigating whether giving house dust mite allergen tablets to infants aged 5 to 12 months can prevent asthma from developing in the first place. Digital health interventions are also being tested: one randomised controlled trial is measuring whether a social intervention promoted by primary care clinicians can improve asthma control in adults.
Despite all this activity, many patients remain unaware that joining a trial is an option. A common misconception is that trials are only for people who have exhausted every other treatment. In reality, many studies actively seek participants with mild or moderate asthma, because researchers need to understand how treatments work across the full spectrum of the condition.
Types of Asthma Clinical Trials Available in the UK
| Trial Type | Example Focus | Typical Duration | Who It Suits | Key Consideration |
|---|
| Biologic therapy trials | Testing new monoclonal antibodies for severe eosinophilic asthma | 12 to 24 months | Adults with uncontrolled severe asthma despite high-dose inhalers | Requires regular clinic visits for injections |
| Prevention studies | House dust mite allergen immunotherapy for infants | Several years | Infants at high risk of developing asthma | Long-term commitment; parents attend appointments |
| Digital intervention trials | Social or behavioural support via apps or online platforms | 6 to 12 months | Adults comfortable with smartphones | Fewer in-person visits; remote monitoring |
| Medication reduction trials | Assessing whether daily medication can be safely reduced | 12 to 52 weeks | Patients whose asthma is well-controlled on current treatment | Close monitoring for symptom changes |
| Drug comparison studies | Head-to-head evaluation of existing treatments | Varies | Broad eligibility across asthma severity levels | May involve placebo arms |
The diversity of trial types means that eligibility is broader than most people assume. A confirmed asthma diagnosis is generally required, and age ranges vary — some studies recruit children as young as 5 months, while others focus on adults up to 80 years old. Screening visits ensure that each participant is matched to a study that is both safe and scientifically appropriate for their situation.
What It Is Actually Like to Take Part
Claire Newman, a 48-year-old from Bexley, received her first dose of tezepelumab at Royal Brompton Hospital after years of struggling with severe asthma that made even basic housework impossible. "My asthma really limits what I can do," she said. "Simple things like just moving around the flat is a real struggle." She had tried earlier biologic treatments without success, but her consultant — one of the clinicians who helped develop the drug — believed this newer option could work for her.
For Elaine in Bradford, the trial involved recording her peak flow readings twice a day and attending the hospital for a monthly injection. She describes the research team as approachable and responsive: "The whole team, the doctors and nurses, are very helpful. You can always ask them any questions at any time." The practical result was tangible: she could walk further without getting out of breath.
These experiences highlight something that trial protocols do not always capture on paper — the level of medical attention participants receive. Unlike routine NHS care, where appointments can feel rushed, trial participants typically benefit from extended consultations, regular lung function tests, and direct access to specialist nurses. Travel expenses for clinic visits are usually covered, and some trials also reimburse other costs such as parking or meals during longer appointments.
The screening process itself is straightforward. After expressing interest, you will attend an initial appointment where the research team reviews your medical history, performs breathing tests, and explains the study in detail. You will receive an informed consent document that outlines the purpose of the trial, what participation involves, and any potential risks. Only after you have had time to ask questions and consider your options will you sign the consent form. You can withdraw from a trial at any point without affecting your standard NHS care.
How to Find and Join an Asthma Clinical Trial
The most accessible starting point is the Be Part of Research website, run by the NIHR. It lists actively recruiting asthma studies across the UK and allows you to filter by location, making it easy to find trials near you. ClinicalTrials.gov is another comprehensive registry, though its international scope means you will need to narrow results to UK-based studies.
Asthma + Lung UK, the country's leading respiratory charity, offers a helpline and online resources that can point you toward relevant research. Their team can explain the difference between types of trials and help you frame questions to ask the research team.
Your GP or asthma nurse is another route. Many general practices receive notifications about local trials and can discuss whether a study might be appropriate for you. If you are under the care of a hospital consultant, they are often best placed to identify trials that match your specific type of asthma, particularly for severe cases where biologic therapies are being tested.
When you contact a research team, expect to be asked about your diagnosis history, current medications, and recent symptoms. The eligibility screening is thorough because it protects both you and the scientific integrity of the study. Do not be discouraged if the first trial you enquire about is not a fit — there are usually multiple studies recruiting at any given time, and research nurses can often suggest alternatives.
The decision to join a trial is personal. Some people are motivated by the chance to access a treatment years before it reaches the NHS. Others are driven by a desire to contribute to medical knowledge that will help future generations. For Elaine, it was both: "If it's a cure for you, or some help, then I'm willing to do that, and it might work for somebody else as well."
研究の知恵